Clinical Trial Update: Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer

View source ↗

Summary

A CHA University-sponsored clinical trial (NCT06893380) is evaluating the combination of GCNT and tislelizumab in locally advanced or metastatic biliary tract c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• GCNT
• Tislelizumab (tislelizumab)

Snippet

Sponsor: CHA University | Conditions: Locally Advanced Biliary Tract Cancers, Metastatic Biliary Tract Cancers | Status: RECRUITING